Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Mol Biol Rep ; 46(4): 3801-3808, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31012028

ABSTRACT

A direct role for IgA either for elimination of malaria parasite or for improvement in tissue pathology has not been investigated in case of Malaria infection while IgG, IgE and IgM were all implicated in the adverse pathology. In this communication, we delineate further that Malaria specific IgA appears to be significant among individuals who had multiple episodes of infection. Interestingly, the IgA elicited by immunization of the homologous peptides derived from Plasmodium berghei ANKA have also resulted in protection of host from adverse lung pathology, while the parasite load is unaffected. The PfrVI immunized mice and mice infected with repeated cycles of 'infection and recovery', simulating an endemic like situation, have resulted in development of B cell population that secretes the IgA specific to this region VI. Summarily, our results suggest that the IgA specific to the malarial antigen can confer significant advantage to hosts in protecting the overall tissue pathology.


Subject(s)
Immunoglobulin A/immunology , Malaria/immunology , Malaria/metabolism , Plasmodium berghei/immunology , Animals , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Erythrocytes/metabolism , Immunization , Ligands , Malaria/pathology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Plasmodium berghei/pathogenicity , Transforming Growth Factor beta/immunology , Transforming Growth Factor beta/metabolism
2.
J Immunol ; 193(7): 3644-53, 2014 Oct 01.
Article in English | MEDLINE | ID: mdl-25187664

ABSTRACT

CD40 plays dual immunoregulatory roles in Leishmania major infection and tumor regression. The functional duality emerges from CD40-induced reciprocal p38MAPK and ERK-1/2 phosphorylations. Because phosphotyrosine-based signaling in hematopoietic cells is regulated by the phosphotyrosine phosphatase SHP-1, which is not implied in CD40 signaling, we examined whether SHP-1 played any roles in CD40-induced reciprocal signaling and anti-leishmanial function. We observed that a weaker CD40 stimulation increased SHP-1 activation. ERK-1/2 inhibition or p38MAPK overexpression inhibited CD40-induced SHP-1 activation. An ultra-low-dose, CD40-induced p38MAPK phosphorylation was enhanced by SHP-1 inhibition but reduced by SHP-1 overexpression. A reverse profile was observed with ERK-1/2 phosphorylation. SHP-1 inhibition reduced syk phosphorylation but increased lyn phosphorylation; syk inhibition reduced but lyn inhibition enhanced CD40-induced SHP-1 phosphorylation. Corroborating these findings, in L. major-infected macrophages, CD40-induced SHP-1 phosphorylation increased and SHP-1 inhibition enhanced CD40-induced p38MAPK activation and inducible NO synthase expression. IL-10 enhanced SHP-1 phosphorylation and CD40-induced ERK-1/2 phosphorylation but reduced the CD40-induced p38MAPK phosphorylation, whereas anti-IL-10 Ab exhibited reverse effects on these CD40-induced functions, identifying IL-10 as a crucial element in the SHP-1-MAPK feedback system. Lentivirally overexpressed SHP-1 rendered resistant C57BL/6 mice susceptible to the infection. Lentivirally expressed SHP-1 short hairpin RNA enhanced the CD40-induced L. major parasite killing in susceptible BALB/c mice. Thus, we establish an SHP-1-centered feedback system wherein SHP-1 modulates CD40-induced p38MAPK activation threshold and reciprocal ERK-1/2 activation, establishing itself as a critical regulator of CD40 signaling reciprocity and mechanistically re-emphasizing its role as a potential target against the diseases where CD40 is involved.


Subject(s)
CD40 Antigens/immunology , Leishmania major/immunology , Leishmaniasis, Cutaneous/immunology , MAP Kinase Signaling System/immunology , Macrophages/immunology , Protein Tyrosine Phosphatase, Non-Receptor Type 6/immunology , Animals , Enzyme Activation/immunology , Interleukin-10/immunology , Intracellular Signaling Peptides and Proteins/immunology , Leishmaniasis, Cutaneous/pathology , Macrophages/pathology , Mice , Mice, Inbred BALB C , Mitogen-Activated Protein Kinase 3/immunology , Nitric Oxide Synthase Type II , Phosphorylation/immunology , Protein-Tyrosine Kinases/immunology , Syk Kinase , p38 Mitogen-Activated Protein Kinases/immunology
3.
Hum Immunol ; 74(1): 28-31, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23000375

ABSTRACT

Interleukin-10 (IL-10) is an anti-inflammatory cytokine that works through IL-10 receptor alpha subunit- and suppresses immune responses in many infectious diseases such as leishmaniasis as well as in cancer. Therefore, in order to restore the host-protective immune responses in such diseases, an antagonist to this cytokine is a pressing need. Herein, using phage peptide library display, we have identified a dodecameric peptide that functions as an antagonist to human IL-10 receptor in an IL-10-induced STAT3 phosphorylation assay. The peptide antagonist's ability to restore anti-leishmanial function in CD40-activated macrophages was also tested. We observed that the peptide reduced IL-10-induced STAT-3 phosphorylation and enhanced CD40-activated leishmanial functions in macrophages.


Subject(s)
Antiprotozoal Agents/pharmacology , Leishmania donovani/drug effects , Macrophages/drug effects , Oligopeptides/pharmacology , Peptide Library , Receptors, Interleukin-10/antagonists & inhibitors , Antiprotozoal Agents/immunology , Antiprotozoal Agents/metabolism , Binding, Competitive , CD40 Antigens/genetics , CD40 Antigens/immunology , Cell Line , Gene Expression/drug effects , High-Throughput Screening Assays , Host-Parasite Interactions/drug effects , Host-Parasite Interactions/immunology , Humans , Interleukin-10/immunology , Interleukin-10/metabolism , Leishmania donovani/physiology , Macrophages/immunology , Macrophages/parasitology , Models, Molecular , Oligopeptides/immunology , Oligopeptides/metabolism , Phosphorylation/drug effects , Protein Binding , Receptors, Interleukin-10/immunology , Receptors, Interleukin-10/metabolism , STAT3 Transcription Factor/antagonists & inhibitors , STAT3 Transcription Factor/genetics , STAT3 Transcription Factor/immunology , Signal Transduction/drug effects
4.
PLoS One ; 4(7): e6293, 2009 Jul 21.
Article in English | MEDLINE | ID: mdl-19621082

ABSTRACT

BACKGROUND: Wild type Staphylococcal alpha-hemolysin (alpha-HL) assembly on target mammalian cells usually results in necrotic form of cell death; however, caspase activation also occurs. The pathways of caspase activation due to binding/partial assembly by alpha-HL are unknown till date. RESULTS: Cells treated with H35N (a mutant of alpha-HL that remains as membrane bound monomer), have been shown to accumulate hypodiploid nuclei, activate caspases and induce intrinsic mitochondrial apoptotic pathway. We have earlier shown that the binding and assembly of alpha-HL requires functional form of Caveolin-1 which is an integral part of caveolae. In this report, we show that the caveolae of mammalian cells, which undergo a continuous cycle of 'kiss and run' dynamics with the plasma membrane, have become immobile upon the binding of the monomer. The cells treated with H35N were unable to recover despite activation of membrane repair mechanism involving caspase-1 dependent activation of sterol regulatory element binding protein-1. CONCLUSIONS: This is for the first time we show the range of cellular changes and responses that take place immediately after the binding of the monomeric form of staphylococcal alpha-hemolysin.


Subject(s)
Apoptosis/physiology , Caspases/metabolism , Hemolysin Proteins/physiology , Membrane Proteins/physiology , Bacterial Toxins , Blotting, Western , Caveolin 1/physiology , Cell Line , Enzyme Activation , Flow Cytometry , Fluorescent Antibody Technique , Humans , Hydrolysis , Phosphatidylserines/metabolism , Poly(ADP-ribose) Polymerases/metabolism
5.
J Biol Chem ; 277(40): 37840-7, 2002 Oct 04.
Article in English | MEDLINE | ID: mdl-12147694

ABSTRACT

The crystal structure of flap endonuclease-1 from Pyrococcus horikoshii (phFEN-1) was determined to a resolution of 3.1 A. The active cleft of the phFEN-1 molecule is formed with one large loop and four small loops. We examined the function of the conserved residues and positively charged clusters on these loops by kinetic analysis with 45 different mutants. Arg(40) and Arg(42) on small loop 1, a cluster Lys(193)-Lys(195) on small loop 2, and two sites, Arg(94) and Arg(118)-Lys(119), on the large loop were identified as binding sites. Lys(87) on the large loop may play significant roles in catalytic reaction. Furthermore, we successfully elucidated the function of the four DNA binding sites that form productive ES complexes specific for each endo- or exo-type hydrolysis, probably by bending the substrates. For the endo-activity, Arg(94) and Lys(193)-Lys(195) located at the top and bottom of the molecule were key determinants. For the exo-activity, all four sites were needed, but Arg(118)-Lys(119) was dominant. The major binding sites for both the nick substrate and double-stranded DNA might be the same.


Subject(s)
DNA, Archaeal/metabolism , Endodeoxyribonucleases/chemistry , Endodeoxyribonucleases/metabolism , Pyrococcus/genetics , Amino Acid Sequence , Amino Acid Substitution , Binding Sites , Cloning, Molecular , Crystallography, X-Ray/methods , DNA Repair , Escherichia coli/genetics , Flap Endonucleases , Models, Molecular , Mutagenesis , Mutagenesis, Site-Directed , Protein Structure, Secondary , Pyrococcus/enzymology , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL